{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:15:21Z","timestamp":1782231321891,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","award":["10141685"],"award-info":[{"award-number":["10141685"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stiftung Pathobiochemie der Deutschen Gesellschaft f\u00fcr Klinische Chemie und Laboratoriumsmedizin","award":["66\/2007"],"award-info":[{"award-number":["66\/2007"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejphar.2016.06.061","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T19:56:29Z","timestamp":1467489389000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Aptamer BC 007 \u2013 A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors"],"prefix":"10.1016","volume":"789","author":[{"given":"Annekathrin","family":"Haberland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holtzhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Schlichtiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Schimke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Luppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Wallukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.06.061_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1166\/jbn.2005.007","article-title":"Design variations for an aptamer-based DNA nanodevice","volume":"1","author":"Beyer","year":"2005","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.autrev.2014.08.021","article-title":"Diagnostic and therapeutic aspects of \u03b21-adrenergic receptor autoantibodies in human heart disease","volume":"13","author":"Bornholz","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2016.06.061_bib3","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1016\/j.healun.2008.11.534","article-title":"527: agonistic autoantibodies against alpha-1 adrenergic and endothelin-1 receptors in Sera of patients with pulmonary arterial hypertension: potential involvement in the pathogenesis of the disease","volume":"28","author":"Dandel","year":"2009","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ejphar.2016.06.061_bib4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/eurjhf\/hfs123","article-title":"Long-term benefits of immunoadsorption in \u03b2(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy","volume":"14","author":"Dandel","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2016.06.061_bib5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2016.06.061_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-014-2057-8","article-title":"Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats","volume":"393","author":"Haberland","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2016.06.061_bib7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCRESAHA.111.253849","article-title":"Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies","volume":"109","author":"Haberland","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2016.06.061_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-3083.2009.02280.x","article-title":"Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors","volume":"70","author":"Hempel","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000376546","article-title":"Questionable validity of peptide-based ELISA strategies in the diagnostics of cardiopathogenic autoantibodies that activate G-protein-coupled receptors","volume":"131","author":"Jahns","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.ejphar.2016.06.061_bib10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","article-title":"Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy","volume":"113","author":"Jahns","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2016.06.061_bib11","doi-asserted-by":"crossref","unstructured":"Jefferis, R., Lefranc, M.-P., 2009. Human immunoglobulin allotypes: possible implications for immunogenicity. mAbs 1, pp.332\u2013338.","DOI":"10.4161\/mabs.1.4.9122"},{"key":"10.1016\/j.ejphar.2016.06.061_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nbt0197-41","article-title":"Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies","volume":"15","author":"Lee","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.184.2.315","article-title":"Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes","volume":"184","author":"Lee","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2016.06.061_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/nat.2014.0529","article-title":"Aptamer oligonucleotides: novel potential therapeutic agents in autoimmune disease","volume":"25","author":"Li","year":"2015","journal-title":"Nucleic Acid Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2016.06.061_bib15","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1097\/00005344-200312001-00021","article-title":"Transfer of rabbit autoimmune cardiomyopathy into severe combined immunodeficiency mice","volume":"42","author":"Matsui","year":"2003","journal-title":"J. Cardiovasc. Pharm."},{"key":"10.1016\/j.ejphar.2016.06.061_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1071-9164(99)90009-X","article-title":"Active immunization of combined beta1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits","volume":"5","author":"Matsui","year":"1999","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2016.06.061_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","article-title":"Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy","volume":"101","author":"M\u00fcller","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2016.06.061_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cardfail.2014.12.005","article-title":"Presence of autoantibody directed against \u03b21-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2016.06.061_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916930008994101","article-title":"Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy","volume":"32","author":"Omerovic","year":"2000","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejphar.2016.06.061_bib20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S1473-0502(10)70040-9","article-title":"39 Glaucoma a new indication for immunoadsorption","volume":"43","author":"Rech","year":"2010","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.ejphar.2016.06.061_bib21","first-page":"170","article-title":"Pathophysiological role of autoantibodies against G-protein-coupled receptors in the cardiovascular system","volume":"10","author":"Schulze","year":"2005","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1089\/nat.2015.0568","article-title":"Aptamers against immunologic targets: diagnostic and therapeutic prospects","volume":"26","author":"Vorobyeva","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ejphar.2016.06.061_bib23","unstructured":"Wallukat, G., 2010a. Identification of agonistic autoantibodies. US7741050B2."},{"key":"10.1016\/j.ejphar.2016.06.061_bib24","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1253\/circj.CJ-12-0212","article-title":"The first aptamer-apheresis column specifically for clearing blood of \u03b21-receptor autoantibodies","volume":"76","author":"Wallukat","year":"2012","journal-title":"Circ. J.: Off. J. Jpn. Circ. Soc."},{"key":"10.1016\/j.ejphar.2016.06.061_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2015.11.001","article-title":"Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: a vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies","volume":"244","author":"Wallukat","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2016.06.061_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2009.06.064","article-title":"Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas\u2019 cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas\u2019 patients","volume":"55","author":"Wallukat","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1139\/y02-160","article-title":"Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia","volume":"81","author":"Wallukat","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib28","unstructured":"Wallukat, G., Nissen, E., M\u00fcller, J., Brinckmann, R., Schimke, I., Kunze, R., 2003a, The pathophysiological role of autoantibodies directed to G-protein coupled receptors and therapeutic strategies of antibody removal. Vols. 1,1, in G-protein coupled receptors and autoantibodies. In: G-Protein Coupled Receptors and Autoantibodies, Affina Academy. Pabst Science Publishers, Lengenrich, pp. 7\u201347."},{"key":"10.1016\/j.ejphar.2016.06.061_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","article-title":"Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases","volume":"36","author":"Wallukat","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-2828(08)80036-3","article-title":"Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops","volume":"27","author":"Wallukat","year":"1995","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2016.06.061_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1586\/eci.11.56","article-title":"Receptor-activating autoantibodies and disease: preeclampsia and beyond","volume":"7","author":"Xia","year":"2011","journal-title":"Expert Rev. Clin. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916304307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916304307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T15:55:33Z","timestamp":1536594933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916304307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":31,"alternative-id":["S0014299916304307"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.061","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer BC 007 \u2013 A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}